Cargando…

Differences in disease phenotype and severity in SLE across age groups

OBJECTIVES: Significant differences have been reported in disease phenotype and severity of systemic lupus erythematosus (SLE) presenting in different age groups. Most indicate a more severe phenotype in juvenile-onset SLE (JSLE). There have been limited studies in older patients and no large studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Ambrose, N, Morgan, T A, Galloway, J, Ionnoau, Y, Beresford, M W, Isenberg, D A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089221/
https://www.ncbi.nlm.nih.gov/pubmed/27147622
http://dx.doi.org/10.1177/0961203316644333
_version_ 1782464236798083072
author Ambrose, N
Morgan, T A
Galloway, J
Ionnoau, Y
Beresford, M W
Isenberg, D A
author_facet Ambrose, N
Morgan, T A
Galloway, J
Ionnoau, Y
Beresford, M W
Isenberg, D A
author_sort Ambrose, N
collection PubMed
description OBJECTIVES: Significant differences have been reported in disease phenotype and severity of systemic lupus erythematosus (SLE) presenting in different age groups. Most indicate a more severe phenotype in juvenile-onset SLE (JSLE). There have been limited studies in older patients and no large studies looking at SLE across all age groups. METHODS: We assessed the effect of age of onset of SLE on the clinical phenotype by analysing data from two large UK cohorts (the UK JSLE Cohort and the UCLH SLE cohort). RESULTS: A total of 924 individuals were compared (413 JSLE, 511 adult-onset SLE). A female preponderance was present, but less pronounced at either end of the age spectrum. Arthritis was more common with advancing age (93% vs 72%, p < 0.001), whereas renal disease (44% vs 33%, p = 0.001), alopecia (47% vs 23%, p < 0.001) and aphthous ulcerations (39% vs 26%, p = 0.001) were more common in the young. Neuropsychiatric lupus was less common in mature-onset SLE (p < 0.01). JSLE was associated more commonly with thrombocytopenia (21% vs 15%, p = 0.01), haemolytic anaemia (20% vs 3%, p < 0.001), high anti-dsDNA (71% vs 63%, p = 0.009), Sm (22% vs 16%, p = 0.02) and RNP (36% vs 29%, p < 0.04) auto-antibodies. Leucopenia increased with advancing age (p < 0.001). Mortality has been declining over recent decades. However, death rates were substantially higher than the general population. The standardized mortality ratio was 18.3 in JSLE and 3.1 in adult-onset SLE. CONCLUSION: These data from the largest-ever direct comparison of JSLE with adult-onset SLE suggest an aggressive phenotype of disease with a worse outcome in patients with JSLE and emphasizes the importance of careful follow-up in this population.
format Online
Article
Text
id pubmed-5089221
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-50892212016-11-14 Differences in disease phenotype and severity in SLE across age groups Ambrose, N Morgan, T A Galloway, J Ionnoau, Y Beresford, M W Isenberg, D A Lupus Papers OBJECTIVES: Significant differences have been reported in disease phenotype and severity of systemic lupus erythematosus (SLE) presenting in different age groups. Most indicate a more severe phenotype in juvenile-onset SLE (JSLE). There have been limited studies in older patients and no large studies looking at SLE across all age groups. METHODS: We assessed the effect of age of onset of SLE on the clinical phenotype by analysing data from two large UK cohorts (the UK JSLE Cohort and the UCLH SLE cohort). RESULTS: A total of 924 individuals were compared (413 JSLE, 511 adult-onset SLE). A female preponderance was present, but less pronounced at either end of the age spectrum. Arthritis was more common with advancing age (93% vs 72%, p < 0.001), whereas renal disease (44% vs 33%, p = 0.001), alopecia (47% vs 23%, p < 0.001) and aphthous ulcerations (39% vs 26%, p = 0.001) were more common in the young. Neuropsychiatric lupus was less common in mature-onset SLE (p < 0.01). JSLE was associated more commonly with thrombocytopenia (21% vs 15%, p = 0.01), haemolytic anaemia (20% vs 3%, p < 0.001), high anti-dsDNA (71% vs 63%, p = 0.009), Sm (22% vs 16%, p = 0.02) and RNP (36% vs 29%, p < 0.04) auto-antibodies. Leucopenia increased with advancing age (p < 0.001). Mortality has been declining over recent decades. However, death rates were substantially higher than the general population. The standardized mortality ratio was 18.3 in JSLE and 3.1 in adult-onset SLE. CONCLUSION: These data from the largest-ever direct comparison of JSLE with adult-onset SLE suggest an aggressive phenotype of disease with a worse outcome in patients with JSLE and emphasizes the importance of careful follow-up in this population. SAGE Publications 2016-05-04 2016-12 /pmc/articles/PMC5089221/ /pubmed/27147622 http://dx.doi.org/10.1177/0961203316644333 Text en © The Author(s) 2016 http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution 3.0 License (http://www.creativecommons.org/licenses/by/3.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Papers
Ambrose, N
Morgan, T A
Galloway, J
Ionnoau, Y
Beresford, M W
Isenberg, D A
Differences in disease phenotype and severity in SLE across age groups
title Differences in disease phenotype and severity in SLE across age groups
title_full Differences in disease phenotype and severity in SLE across age groups
title_fullStr Differences in disease phenotype and severity in SLE across age groups
title_full_unstemmed Differences in disease phenotype and severity in SLE across age groups
title_short Differences in disease phenotype and severity in SLE across age groups
title_sort differences in disease phenotype and severity in sle across age groups
topic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089221/
https://www.ncbi.nlm.nih.gov/pubmed/27147622
http://dx.doi.org/10.1177/0961203316644333
work_keys_str_mv AT ambrosen differencesindiseasephenotypeandseverityinsleacrossagegroups
AT morganta differencesindiseasephenotypeandseverityinsleacrossagegroups
AT gallowayj differencesindiseasephenotypeandseverityinsleacrossagegroups
AT ionnoauy differencesindiseasephenotypeandseverityinsleacrossagegroups
AT beresfordmw differencesindiseasephenotypeandseverityinsleacrossagegroups
AT isenbergda differencesindiseasephenotypeandseverityinsleacrossagegroups